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Summary: A lumiüol-dependent non-opsonized zymosan-induced chemiluminescence method for phagocytes
in small quantities of whole blood (40 ; final dilution: l : 14) is described. It was characterized with reference
to cellular and humoral components, and also applied to isolated neutrophils, eosinophils and monocytes.
Normal values for whole blood chemiluminescence and for neutrophils, eosinophils and monocytes are
presented. From the chemiluminescence characteristic of distinct phagocytes and their frequency distribution
pattern in whole blood, it is concluded that whole blood chemiluminescence has its source predominantly in
neutrophils. The question äs to the origin of chemiluminescence in phagocytes of whole blood and isolated
neutrophils is investigated. The results support the importance of the myeloperoxidase-H2O2-halide System,
but also go beyond this. The release of arachidonic acid by phospholipase A2 and of diacylglycerol and
inositol trisphosphate by phospholipase C, the metabolism of arachidonic acid by the cyclooxygenase and
lipoxygenase pathway, the activation of membrane NADPH oxidase by diacylglycerol and the calcium
mobilisation by inositol trisphosphate are necessary for the chemiluminescence reaction. Inhibition of either
mechanism suppresses the chemiluminescence response. The interaction of non-opsonized zymosan with
plasma opsonins, phagocyte Fc- and complement receptors, respectively, for the initiation of chemilumines-
cence, was investigated. Non-opsonized zymosan initiates a chemiluminescence response in blood phagocytes
in the absence of opsonin from the interaction of the zymosan polysaccharide component glucan with
the complement receptor type 3. In the presence of plasma this receptor type also mediates the major
chemiluminescence response brought about by the zymosan-coated cleavage products of complement fraction
three, iC3b and to a minor degree G3b, while immunoglobulin G-coated zymosan interaction with the Fc-
receptor is in this case of minor importance.
' Q uc.On Superoxide anion (Öi), hydrogen peroxide (H2O2),
\ Upon interaction with particulate Stimuli or chemical and probably hydroxyl radical (· OH) and singlet
s Stimulation, polymorphonuclear Jeuköcytes (neutro- oxygen (* 2) (1). These excited oxygen species react
philic and eosinophilic granulocytes), monocytes and with certain biological Substrates to become electroni-
macrophages respond with a chain of biochemical cally excited products which generate light upon re-
i and cytophysioiogical events commonly known äs laxation. The relatively poor quantum yield of this
' the respirätory burst native chemiluminescence can be increased more than
a thousand fold by using cyclic hydrazides such äs
This respiratory burst is characterized by an increase .̂̂  as ̂  bystander substrate.
in glucose dehydrogenation via the hexose mono-
phosphate shunt and a non-mitochondrial increase Many investigators have employed luminol-enhanced
in oxygen consumption. By enzymatic and non-en- chemiluminescence of isolated polymorphonuclear
zymatic reactions, oxygen is largely converted into leukocytes to measure their oxygenation capacity or,
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with a constant granulocyte concentration and vari-
able amounts of plasma, the opsonic capacity of
plasma (2).
The high sensitivity of chemilummogenic probing,
however, allows measurement of phagocyte oxygena-
tion activity using diluted native whole blood (see
I.e. (l, 2) for examples). The numerous cellular and
humoral components which modulate and contribute
to the chemiluminescence response of whole blood,
have not, however, been well defined. In the first
part of our work the influence of plasma and of
erythrocytes äs well äs the contribution of phagocytes
other than neutrophilic granulocytes were investi-
gated separately. Normal values for chemilumines-
cence in whole blood and isolated blood cells (neutro-
phils, eosinophils, monocytes) were established.
The second part of our work contributes to the ongo-
ing controversy concerning the origin of zymosan-
induced luminol-dependent chemiluminescence.
The myeloperoxidase H2O2-halide system, seen äs
responsible in the generation of singlet oxygen and
hypochlorous acid for chemiluminescence in acti-
vated neutrophils (3) was recently challanged by
Cheung et al. (4) who postulated that the metabolism
of arachidonic acid via the lipoxygenase and cyclo-
oxygenase pathway is the source of chemilumines-
cence.
We investigated the influence of supplemented Super-
oxide dismutase, catalase and myeloperoxidase, of
metabolic Inhibitors and of scavengers of reactive
oxygen species on chemiluminescence in whole blood
and isolated neutrophils.
It was concluded that the interaction between the
NADPH oxidase system and arachidonic acid metab-
olism generates chemiluminescence but that each Sys-
tem alone does not.
In the last part of our study we examined the impor-
tance of ligand-receptor-mediated initiation of chemi-
luminescence in phagocytes.
Efficient interaction between phagocytes and parti-
cles requires the participation of opsonins, serüm
proteins such äs inimunoglobulin G, and the opsonic
fragments of complement factor three (C3) which
become attached to the surface of microorganisms or
other particles and interact with specific receptors
on phagocytic cells (5, 6). For zymosan there are
conflicting results regarding its interaction with cer-
tain cell types, even in the absence of opsonins (5, 7).
We investigated the initiation of chemiluminescence
in whole blood and isolated neutrophils with opsonin-
coated zymosan and non-opsonized zymosan äs well
äs the influence of chemicals and antibodies directed
against specific opsonins or against distinct comple-
ment receptor types on the phagocyte membrane.
Our results shöw that all blood cell phagocytes can
interact with zymosan via chemiluminescence re-
sponse without any opsonin. From this study and the
published evidence available, a onodel suggesting the
origin of non^opsonized zymosan-induced and lumi-
nol-enhanced chemiluminescence in whole blood and
neutrophils is presented.
Materials and Methods
Chemicals, media and reagents
Sigma Chemicals Co., Louis, USA: Zymosara A from Saccharo-
myces cerevisiae; N-fonnyl-1-L-methionyl-L-leucyl-L-phenyl-
alanine (f-Met-Leu-Phe); catalase (EC 1.11.1.6) from bovine
liver (2890 U/mg); nordihydroguaiaretic acid; indometacin;
benzoic acid (sodium salt); dimethyl sulphoxide; quinacrme;
arachidonic acid from porcine liver; dibütyryl cAMP; theöphyk
line; N-acetyUZ^glucosämine; human immunoglobulin G; anti-
human complement C3; anti-human immunoglobulin G (whole
molecule); prostaglandin Et; prostaglandin E2.
Boehringer Mannheim GmbH, FRG: Luiniiiol
dihydro-1.4-phthalazinedione); phosphate-buffered saline Dul-
becco without Ca2+ and Mg2+; Minimal Essential Medium
Dulbecco fof chemiluminescence with N-2-hydroxyethylpipera^
zine-N^2-ethane sidphonic acid (HEPES), without phenol red,
without glutamine; Superoxide dismutase (EC 1.15.1-1) from
bovine erythrocytes (5000 U/mg).
Bayer, Leverkusen, FRG: Chlorpromazine (Megaphen®).
E. Merck, Darmstadt, FRG: L-alanine; .D-mannitol; £-histi-
dine; ethylenediaminetetraacetic acid (EDTA); sodium azide;
sodium Chloride; triethylamine; Türk's sölution; May Grünwald
stain; Giemsa stain; sodium fluoride. Myeloperoxidase (EC
1.11.1.7) was donated by Dr. S. Neumann.
Pharmacia Fine Chemicals, Sweden: Percoll® (Polyvinylpyrol^
idone-coated silica gel) for density gradient centrifugation.
Fresenius, Bad Homburg, FRG: Sodium citrate sölution (31.3
g/l).
Lumac, Düsseldorf, FRG: Polystyrol chemiluminescence vials
(12 mm 47 mm).
Gödecke AG, Berlin, FRG: Thrombofix sölution.
Ortho Diagüostic Systems, Neckargemünd, FRG: OKM l
monoclonal antibody. Anti C3b (mönoclorial) was donated by
Dr. A. -M. Gundermann.
Blood
Venous blood, anticöagulated with sodium citrate (9 vol blood
H- l vol sodiuin citrate) was öbtaihed from healthy blood
donors from the local blood bank. To avoid day time depen-
dence on respiratory bürst aötivity of phagocytic blood cells
(8), blood was taken between 8.30 and 9.30 a. m.
Plasma
An aliquot of the venous iblood was removed and centrifuged at
12 000 g for 2 min on an Eppendorf centrifuge 3200 (Netheler &
Hinz, Hamburg) at room temperatüre.»
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Haemoglobin
Haemoglobin was determined in whole blood and isoiated
erythrocytes s cyantnethaemoglobin (9).
Isolation of blood cells
Polymorphonudear cells
A two-step discontinuous gradient was established with 4ml
each of the following two Solutions: stock isoosmotic Percoll
diluted with sodium Chloride (0.15 mol/1) to p = 1.0945 kg/l
and p = 1.0779 kg/l (10). Blood (up to 4ml) was applied to
the top of the gradient and after centrifugation (350 g, 25 min,
20 °C, Minifuge GL with a swing-out rotor, Heraeus Christ),
polymorphonuclear cells were separated from the interface of
the two density concentrations. Contaminating erythrocytes
were lysed by hypotonicity. Polymorphonuclear cells were
washed twice in phosphate-buffered saune and adjusted to l — 2
χ l O6 cells per ml in Minimal Essential Medium according to
staining with Turtfs solution. Purity was 98—100%.
Erythrocytes
Erythrocytes were banded at the bottom on the two-step dis-
continuous Percoll gradient. They were recovered and washed
once in phosphate buffered saline. As the density of erythro-
cytes and polymorphonuclear cells overlap (10), the erythro-
cytes were again centrifuged on 4ml Percoll with p = 1.0945
kg/l. After this the erythrocytes were washed twice in phos-
phate-buffered saline and resuspended in Minimal Essential
Medium to a haematocrit of 0.50. The erythrocytes were essen-
tially free of polymorphonuclear cells.
Chemiluminescence
Chemiluminescence assays in whole blood and isoiated blood
cells were performed on a Biolumat 9505 with a six channel
device interconnected with an Apple He, a floppy disk II, a
video display and an Epson MX 82F/T printer (Laboratorium
Prof. Dr. Berthold, Wildbad, FRG) in polystyrene chemilumi-
nescence vials at 37 °C.
Standard assay
Luminol
Luminol (22.6 mmol/1) was prepared daily in Minimal Essential
Medium containing triethylamine (40 mmol/1). Luminol final
assay concentration: 0.4 mmol/1.
'Non-opsonized zymosan
Zymosan particles were washed twice in phosphate buffered
saline, resuspended in Minimal Essential Medium to 100 g/l
and stored frozen at -70°C in small aliquots. Zymosan final
assay concentration: 3.5 g/l.
Pipetting scheine see page 768
Modification of the chemiluminescence Standard as-
say
%
In order firstly to optimize the assay and secondly to study the
humoral and cellular aspects of whole blood and isoiated cell
chemiluminescence, the following modifications and additions
were made.
Mononuclear cells and monocytes
Blood cells, depleted fr m platelet-rich plasma, were centri-
fuged on the two-step discontinuous Percoll gradient described
for polymorphonuclear cells. Mononuclear cells were harvested
from the top of the upper layer, washed twice in phosphate-
buffered saline and resuspended in Minimal Essential Medium.
Monocytes were identified by esterase staining. The fraction of
monocytes in the mononuclear cell Suspension ranged from
0.17 to 0.26 (χ ± SD: 0.23 ± 0.03). The monocyte concentra-
tion was adjusted to 1—2 χ 106/ml in Minimal Essential
Medium irrespective of the total mononuclear concentration.
It has been demonstrated that the chemiluminescence activity
of mononuclear cells is due to the monocytes and not to
lymphocytes (11). Contamination with polymorphonuclear
cells was less than 1%.
Eosinophils
Human eosinophils are denser than neutrophils, but the r nge
of densities of the two cell types overlap. However, if neutro-
phils are exposed to the chemotactic peptide f-Met-Leu^Phe,
which d es not stim iate eosinophils, the neutrophil density
decreases, shifting them away from the density of eosinophils
(12).
Wh ie blood (4ml)i which had been exposed for 15 min at
37 °C tp the chemotactic peptide f-Met-Leu-Phe at 10"6 mol/1,
was added to a three Step discontinuous gradient of each 3 ml
stock isoosmotic Percoll diluted with sodium Chloride (0.15
mol/1) to p = 1.0945 kg/l, 1.0808 kg/l and 1.0779 kg/l and
processed s described in the section "polymorphonuclear
cells".
The cell layer between the interface of both l wer density
concentrations was harvested, washed twice in phosphate-buf-
fered saline and the cell count adjusted to 1-2 χ 106/ml in
Minimal Essential Medium. After Pappenheim staining, purity
was 77%.
Luminol
The final assay concentration of luminol ranged from 0.04
mmol/1 to 2 mmol/1. Various volumes of luminol were balanced
with different volumes of Minimal Essential Medium. Whole
blood volume (40 μΐ) and non-opsonized zymosan (20 μΐ) were
constant.
Zymosan
The final assay concentration of non-opsonized zymosan
ranged from 0.35 g/l to 35 g/l. Various volumes of non-opso-
nized zymosan were balanced with different volumes of Mini-
mal Essential Medium. Whole blood volume (40 μΐ) and lumi-
nol (10 μΐ) were constant.
In some experiments (see tab. 4) opsonized zymosan was used.
Zymosan, washed with phosphate-buffered saline (100 g/l), was
incubated with normal human pooled plasma at 37 °C for 30
min, washed twice in phosphaterbuffered saline, resuspended
in Minimal Essential Medium to 100 g/l and stored frozen
at — 70 °C in small aliquots. Opsonized zymosan final assay
concentration: 3.5 g/l.
Red blood cells
Various quantities of red blood cells were added in a constant
volume of 20 μΐ Minimal Essential Medium. Expressed s final
assay haemoglobin concentration, the concentration r nge was
from 0.25 g/l to 5.5 g/l (flg. 1). Luminol (10 μΐ), plasma (20
μΐ), neutrophil number (0.5 χ l O5) and non-opsonized zymosan
(20 μΐ) were constant.
Plasma volume
Whole blood chemiluminescence was performed with various
voluraes of plasma (flg. 2). Plasma volume varied in the r nge
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Pipetting scheme
Chemiluminescence reaction mixtures were prepared s follows (volume in μΐ) for
a. whole blood and
b. isolated blood cells.
a. Whole blood
channel 1/2 channel 3
Stimulation Γ blank l











5 min incubation 37 °C
20


































5 min incubation 37 °C
20
Chemiluminescence was continuously recorded until it demonstrated a defmite decline. Two chemiluminescence parameters were
calculated from the measurements:
(i) peak maximum counts/min values of Stimulation reaction. Whole blood: counts/min χ 2 χ ΙΟ5 granulocytes; isolated cells:
counts/min χ 0.5 χ l O5 cells.
(ii) peak time values (time in min after starting the Biolumat required to reach the peak maximum).
15 ul to 50 μΐ and was balanced with different volumes of
Minimal Essential Medium. Luminol (10 μΐ), neutrophils (0.5
χ l O5), red blood cells (20 μΐ) and non-opsonized zymosan (20
μΐ) were constant.
Red blood cells and plasma volume
Various combinations of red blood cells and plasma in Minimal
Essential Medium (from 5 μΐ red blood cells + 35 μΐ plasma
to 30 μΐ red blood cells H- 10 μΐ plasma) were added in a
constant volume of 40 μΐ (flg. 3). Luminol (10 μΐ), neutrophils
(0.5 χ l O5) and non-opsonized zymosan (20 μΐ) were constant.
Granulocytes
Additional granulocytes in Minimal Essential Medium (from
5 χ l O3 to 5 χ l O5 cells) were added to whole blood (fig. 4).
Various added volumes were balanced with different volumes
of Minimal Essential Medium. Luminol (10 μΐ), whole blood
(40 μΐ) and non-opsonized zymosan (20 μΐ) were constant.
Plasma composition
Two experiments were performed to investigate the role of
plasma in whole blood chemiluminescence and in chemilumi-
nescence of isolated neutrophils. Methodological procedure
and results are presented in table l and table 2.
Addition of Superoxide dismutase, myeloperoxidase
and catalase
Superoxide dismutase, myeloperoxidase and catalase were dis-
solved in and diluted with Minimal Essential Medium to give
final assay catalytic activity concentrations of 400 k /1, 200
U/l and 4800 kU/1, respectively. Experiments were performed
with whole blood and isolated neutrophils. Whole blood experi-
ments included the Standard assay procedure with non-opso-
nized zymosan and also opsonized zymosan and plasma-de-
pleted whole blood (washing three times) with opsonized zymo-
san. Experiments with neutrophils followed the same scheme.
All enzymes were incubated with whole blood or neutrophils,
in the presence of luminol in Minimal Essential Medium for
5 min at 37 °C; reaction was initiated with non-opsonized or
opsonized zymosan. Results are expressed s the quotient of
chemiluminescence peak maximum values (CL l — K 1) in the
presence and in the absence of enzymes (tab. 4).
Addition of metabolic inhibitors and scavengers of
reactive oxygen species
Nordihydroguaiaretic acid was dissolved in dimethylsulphoxide
to 10 mmol/1 and further diluted in Minimal Essential Medium.
Final assay concentration: 0.1 mmol/1. Dimethylsulphoxide has
been reported to be a hydroxyl radical scavenger (4). Our
control experiments showed, however, that the amount of di-
methylsulphoxide we used did not affect the magnitude of the
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chemiluminescence response. Arachidonic acid and prostaglan-
din Et and £2 were dissolved in ethanol to 30.6 mmol/1 and 2.8
mmol/1, respectively, and further diluted in Minimal Bssential
Medium. Final assay concentration: 0.05 mmol/1 and 0.03
mmol/1, respectively. All other drugs were dissolved in Minimal
Essential Medium. Final assay concentration in brackets: L-
alanine (10.5 mmol/1); £-mannitol (40 mmol/1); sodium ben-
zoate (1.5 mmol/1); L-histidine (21 mmol/1); sodium azide
(l mmol/1); cyanide (l mmol/1); indometacin (l mmol/1); quina-
crine (l mmol/1); dibutyryl cAMP (l mmol/1); theophylline
(2 mmol/1); NaF (20 mmol/1); chloφΓomazine (0.1 mmol/1).
All drugs were incubated with whole blood or neutrophils in
the presence of luminol in Minimal Essential Medium for 10
min at 37 °C; reaction was initiated with non-opsonized zymo-
san. Results are expressed s the quotient of chemiluminescence
peak maximum values (CL l —K 1) in the presence and in the
absence of inhibitors or scavengers (tab. 5).
Receptor studies
N-acetyl-/>-glucosamine (200 mmol/1) and EDTA (3 mmol/1)
were incubated with neutrophils or whole blood for 10 min at
37 °C before the Start with non-opsonized zymosan according
to the Standard procedure. Autologous plasma (20 μΐ) or immu-
noglobulin G solution (20 μΐ of 11 g/l) are the source of
particular opsonins in the experiments with isolated neutro-
phils. Among opsonins, complement C3, complement C3b and
immunoglobulin G were inhibited with anti-human comple-
ment C3, anti-human complement C3b and anti-human immu-
noglobulin G (whole molecule), respectively, and with a combi-
nation of anti-immunoglobuHn G and anti-complement C3.
Appropriate dilutions of plasma and immunoglobulin G solu-
tion with antibodies were prepared according to the titre, s
given by the manufacturer. The monoclonal antibody OKM l
final assay concentration was 5 mg/1.
Results
Optimizatipn of whole blood chemilumines-
cence; reference values
Luminol
With different luminol concentrations peak max-
imum is reached between 0.3 to 0.5 mmol/1 final assay
concentration (not sh wn). In furthef experiments a
luminol final assay concentration of 0.4 mmol/1 was
used.
Non-opsonized zymosan
A steady increase of photon emission was observed
with increasing zymosan particle concentration (not
shown). In further experiments a non-opsonized
zymosan final assay concentration of 3.5 g/l was usecL
Erythrocytes
Figure l gives the relationship between increasing
numbers of erythrocytes (g haemoglobin per l final
assay) and constant numbers of granulocytes (0.5 χ
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Fig. l . Dependence of erythrocyte concentration (haemoglo-
bin, g/l assay) on chemiluminescence peak maximum
(counts/min χ 2 · l O5 granulocytes) and on peak time
(min) in whole blood. Various volumes of erythrocytes
were balanced with Minimal Essential Medium. Lumi-
nol (10 μΐ; 0.4 mmol/1 final assay), non-opsonized zymo-
san (2Q μΐ; 3.5 g/l final assay), granulocyte number (0.5 ·
l O5), plasma volume (20 μΐ) and final lest volume of
570 μΐ are constant. Peak maximum values are plotted
separately for each of the 5 probands. Peak times are
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Fig. 2. Dependence of plasma volume fraction on chemilumi-
nescence peak maximum (counts/min χ 2 · l O5 granulo-
cytes) and on peak time (min) in whole blood. Various
volumes of plasma (from 15 μΐ to 50 μΐ) were balanced
with Minimal Essential Medium. Luminol (10 μΐ; 0.4
mmol/1 final assay), non-opsonized zymosan (20 μΐ; 3.5
g/l final assay), granulocyte number (0.5 · l O5), erythro-
cyte volume (20 μΐ) and final test volume of 570 μΐ are
constant. Peak maximum values are plotted separately
for each of the 5 probands. Peak times are plotted s
means ± SD.
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With increasing numbers of red blood cells, peak
maximum values are drastically reduced, whereas
time peak values remain unchanged.
Plasma volume
On the other band, if the numbers of erythrocytes
and neutrophils are kept constant in an increasing
plasma volume, the peak maximum increases and the
peak time values become shorter (fig. 2).
Plasma volume and erythrocytes
Different combinations of plasma and red blood cells
in a given constant volume of 40 μΐ with a constant
number (0.5 χ l O5) of neutrophils confirm both
previous experiments. A shift to a higher volume
fraction of erythrocytes against a lower volume frac-
tion of plasma diminishes peak maximum counts and
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Fig. 3. Dependence of di erent ratios of plasma volume vs.
erythrocytes on chemiluminescence peak maximum
(counts/min χ 2 · l O5 granulocytes) and on peak time
(min) in artificial whole blood. in a constant volume of
40 μΐ erythrocytes and plasma volume varied from 5 μΐ
erythrocytes plus 35 μΐ plasma to 30 μΐ erythrocytes
plus 10 μΐ plasma. Luminol (10 μΐ; 0.4 mmol/1 final
assay), non-opsonized zymosan (20 μΐ; 3.5 g/l final
assay), granulocyte number (0.5 · l O5) and final test
volume of 570 ul are constant. Peak maximum values
are plotted separately for each of the 5 probands. Peak
times are plotted s means ± SD.
Granulocytes
Figure 4 demonstrates that a proportional depen-
dency exists between whole blood peak maximum
val es and granulocyte number. It is therefore pos-
sible to calculate a standardized chemiluminescence
peak maximum for any blood sample, based on a
fixed number f granulocytes. tndividual peak time
values are also unchanged (not shown). As each of
the five probands has a different original whole blood
granulocyte number to which additional granulocytes
were added, a conaprehensive graphical representa-
tion of peak time mean val es is not possible.













Fig. 4. Dependence of granulocyte number on chemilumines^
cence peak maximum (counts/min) in whole blood,
Increasing granulocyte numbers (up to 500 · l O3 cells)
were added. Luminol (10 μΐ; 0.4 mmol/1 final assay),
non-opsonized zymosan (20 μΐ; 0.4 mmol/1 final assay)
and final test volume of 570 μΐ are constant. The values
are plotted separately for each of the 5 probands.
Plasma composition
Washing of whole blood and readj stmeiit to its in-
itial haemqglobin cpncentration with autologous
plasma does not alter the pverall chemiluminescence
response (tab. 1). On the other band, Substitution
of plasma by buffer solution, by complement C3b-
inactivated plasma (30 min 56 °C) or by complement
C3b-desorbed plasma (100 mg zymosan per ml
plasma, 30 min 37 °C) reduced the chemiluminescence
response and shortened peak time values. Comple-
ment fraction C5a alone without non-opsonized
^zymosan, is therefore not a potent Stimulus for the
L C n. Chem. Clin. Biochem. / Vol. 25,1987 / No. 11
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chemiluminescence response. These results contradict in the plasma fraction or its depletion from plasma
those obtained for peak time values using isolated by zymosan desorption results in diminished chemilu-
granulocytes (tab. 2). Complement C3b inactivation nainescence but lengthens peak time.
Tab. 1. Chemiluminescence in untreated whole blood and in artificial whole blood whose plasma component has been replaced
or treated in various ways s shown in the scheine. Peak maximum (CL l, K 1; l O3 counts/min χ 2 χ ΙΟ5 granulocytes)
and peak time (min) are given s mean ± SD; n = 11. n.d.: no clear cut peak time.
.Whole blood\
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Tab. 2. Chemiluminescence in isolated granulocytes with the addition of plasma treated in various ways s shown in the scheme.
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Normal values
Normal values for chemiluminescence in whole blo d
and isolated phagocytes are given in tab. 3. Peak
maximum values for granulocytes in whole blood are
only about 0.05 of those for isolated neutrophils,
based on the standardized phagocyte number.
Among isolated blood cells the neutrophils and eosi-
nophils have an identical chemiluminescence pattern.
Peak maximum (CL 1) values for monocytes, how-
ever, are only 0.3 ofthose for neutrophils and eosino-
phils. The peak maximum values (CL 2) for all three
cell types are high and it is worth noting that this is
the only non-opsonized zymosan triggered response
without any opsonin.
Superoxide dismutase, myeloperoxidase and
catalase
Addition of Superoxide dismutase (tab. 4) to either
whole blood or neutf phil assays diminished the che-
miluminescence response; myeloperoxidase increased
the response, whereas catalase additio resulted in
an increased response in the whole blooci assay but
Tab. 3. Normal values for chemiluminescence in a) whole blood and b) isolated blood cells.
Whole blood: n = 81; 50 males, 31 females
Neutrophils: n = 54; 32 males, 22 females
Eosinophils: n = 8; 6 males, 2 females
Monocytes: n = 13; 11 males, 2 females
All values s mean ± Standard deviation.
a) Whole blood
Peak maximum (CL 1)























































































Tab. 4. Influence of Superoxide dismutase, myeloperoxidase and catalase on zymosan-induced (non-opsonized and opsonized)
chemiluminescence in whole blood and isolated neutrophils. Results are expressed s quotients of chemiluminescence
peak maximum values (CL l — K 1) in the presence and in the absence of these enzymes. Final assay concentration of
enzymes in brackets. Whole blood (20 μΐ) or isolated neutrophils (0.5 χ l O5) were preincubated at 37 °C for 5 min with
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a reduced response Tor isolated neutrophils. To clarify
the degree of contribution of naturally occurring
plasma cnzymcs, Stimulation with opsonized, äs well
äs non-opsonized zymosan and the effect of addition
or withdrawal of plasma were studied.
Metabolie Inh ib i t o r s and scavengers of reac-
tive oxygen species
When phagocytes in whole blood or isolated neutro-
phils were subjected to the inhibitory effects of ala-
nine (scavenger of HC1O), mannitol and sodium ben-
zoate (scavengers of hydroxyl radical) and histidine
(scavenger of singlet oxygen) (4, 13), the most ap-
prcciable effect was observed for sodium benzoate.
Azide, known to be an inhibitor of haem enzymes like
catalase and myeloperoxidase (l3), totally suppressed
chemiluminescence, whereas cyanide, which addition-
ally inhibits Superoxide dismutase had only a moder-
ate inhibitory effect (tab. 5).
Inhibitors of arachidonic acid metabolism are very
powerful inhibitors of the chemiluminescence re-
sponse. Nordihydroguaiaretic acid was used to inhibit
the lipoxygenase pathway (4), indometacin to inhibit
the cyclooxygenase pathway (4), and quinacrine to
inhibit arachidonic acid production from membrane
phospholipids, presumably by phospholipase A2 Inhi-
bition (14).
When arachidonic acid, the Substrate for both the
lipoxygenase and the cyclooxygenase pathways was
added, a small inhibitory effect was observed. Intra-
cellular cAMP, which inhibits phosphoinositide turn-
over in human neutrophils (l 5), was raised by prein-
cubation eithcr with dibutyryl cAMP and/or the-
ophylline (15), with prostaglandins or with NaF (4).
It was found that all agents effectively suppressed the
chemiluminescence response.
Inhibition of the ubiquitious calcium-binding protein
calmodulin, using chlorpromazine (16), largely dimin-
ished chemiluminescence in both whole blood and
isolated neutrophils.
Receptor studies
N-acetylglucosamine and EDTA have been reported
to inhibit complement rcceptor type thrce mcdiated
unspecific binding to non-opsonized zymosan and to
C3b fragment coated zymosan and to have no detcc-
table effect on complement receptor type one or Fc-
receptors (5). In our chemiluminescence assay EDTA
blocked almost every response, irrespective of the
particular opsonin added to the isolated neutrophils
or the naturally occurring and generating opsonins
in whole blaod.
N-acetylglucosamine also effectively reduced the che-
miluminescence response. In contrast to the above
mentioned specificity, however, it also affects the Fc-
receptor mediated response, äs becomes evident from
the results using immunoglobulin G äs the specific
opsonin.
Anti-imnnunoglobulin G had no effect on isolated
neutrophils when plasma (i.e. mainly IgG and nas-
cent C3b) served äs opsonins. This contrasts markedly
with the response found in the whole blood assay.
Tab. 5. Inhibition of non-opsonized zymosan-induced chemiluminescence of phagocytes in whole blood and of isolated polymor-
phonuclear leukocytes by metabolic inhibitors and by scavengers of activated oxygen species. Inhibition is expressed äs
the quotient of chemiluminescence peak maximum values (CL l —K 1) in the presence and in the absence of inhibitors
or scavengers. Final assay concentration of inhibitors and scavengers in brackets. Whole blood (20 ) or isolated
polymorphonuclear cells (0.5 l O5) were preincubated at 37 °C for 10min with inhibitors or scavengers before non-
opsonized zymosan was added. ± SD of four to five paired experiments.
Addition Whole blood Neutrophils
Alaninc (10.5 mmol/1)
Mannitol (40 mmol/1)




Nordihydroguaiaretic acid (0.1 mmol/1)
Indometacin (1 mmol/1)
Quinacrine (1 mmol/1)
Arachidonic acid (0.05 mmol/1)
Dibutyryl cAMP (1 mmol/i)
Theophylline (2 mmol/1)
Dibutyryl cAMP (1 mmol/1) H- theophylline (2 mmol/1)
Prostaglandin E, (0.03 mmol/1)
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Anti-complement C3, on the other band, has a greater
reducing effect in the neutrophil assay with plasrna
äs the source of opsonins than in the whole blood
assay. Anti-complement C3b is without any significant
effect.
A variety of monoclonal antibodies, including
OKM l, recognize a cell surface molecule on phago-
cytes and it is suggested that this cell surface antigen
is the iC3b receptor (5, 6). In the case of chemilumines-
cence, however, OKM l caused only slight Inhibition
in the whole blood assay and in the assay with iso-
lated neutrophils with plasma äs the opsonin source.
Discussion
Optimization of whole blood chemilumines-
cence; normal values for whole blood and
isolated phagocytes
Dilutions of whole blood in the final assay mixture
in reported methods for whole blood chemilumines-
cence ränge from l : 5 to l : 8000 (see I.e. (l, 2)). In
our System blood is finally diluted 1:14. If quantita-
tion of phagocyte-specific oxygenation activity is the
sole objective of testing, relatively high dilutions of
blood are needed. A t a whole blood dilution of
l : 8000 to peak maximum nearly equals that of iso-
lated granulocytes (1). Photon yield is drastically re-
duced with increasing erythrocyte haemoglobin con-
centration (fig. 1). The peak maximum of whole
blood phagocytes is only about 0.05 of that for an
equivalent number of isolated granulocytes (tab. 3).
There are three possible reasons for this phenomenoii.
Firstly, most of this decrease could be a physical
consequence of photon absorption by haemoglobin
(1). Secondly, erythrocytes serve äs potent scävengers
of activated oxygen species in vivo (17, 18) and in
vitro (13). Thirdly, compared with isolated granulo-
cytes, whole blood phagocytes possess distinctly
fewer type l and type 3 complement receptors, both
in the resting state, and after Stimulation by activating
Stimuli (6), and they thus alter the activation profile.
The importance of cell surface receptors on phagocy-
tes and of plasma opsonins is discussed in detail
below.
It is generally accepted, that lymphocytes and throm-
bocytes do not directly contribute to zymosan4n-
duced chemiluminescence (11).
The relatively identical activation characteristic of
granulocytes, i. e. neutrophils and eosinophils and the
wer peak maximum values for stimulated monocy-
tes (tab. 3) has, on the whole, been confinned in
comparative studies with eosinophils vs. neutrophils
(19) and monocytes vs. neutrophils (20). Neutrophils,
eosinophils and monocytes account for 0.87, 0.04 and
0.09, respectively, of the phagocytes in normal blood.
According to the Stimulation and distribution pattern
of phagocytes, it is concluded that whole blood che-
miluminescence is mainly the response of neutrophils.
This is strengthened by the fact that proportional
dependency exists between whole blood peak max-
imum values and granulocyte number (flg. 4). This is
the basis for expressing whole blood chemilumines-
cence on the basis of a constant cell number, i
dent of other cellular and humoral impjications.
Addition of Superoxide dismutase, myelo^
peroxidase, catalase and of Metabolie in-
hibitors and scavengers of reactive oxygen
species
Luminol-dependent chemiluminescence seenis to be
completely linked with a reaction liiediated by the
myeloperoxidase*H2O2-halide System, whereäs native
luminol-independent chemiluminescence is also re-
lated to a not yet elucidated O2-mediated reaction (3,
21—23). These two obviously different mechanisms
should be distinguished from one another, äs well äs
the Stimulation with distinct particulate or söluble
agents. Cheung et al. (4), however, postulated that
the lipöxygenase (and cyclooxygenase) pathway is the
source of zymosan-induced and luminol-enhanced
chemiluminescence.
It should be clearly stated that only the mechanism
of zymosan-stimulated luminol-dependent chemilu-
minescence is ünder discussion here. That the reactive
oxygen species alone are the>source of chemilumines^
cence is contradicted by the following observatioils:
1. Superoxide dismutase and catalase cannot comple-
tely inhibit chemiluminescence, regardless of the
quantity of inhibitors used (3, 4). We even find aug-
mented chemiluminescence in whole blood upon ad-
dition of catalase (tab. 4). This must be dtie to some,
until now unexplained, prpperties of the weak ery-
throcyte chemiluminescence response (24).
2. Previous studies have revealed that the excited
oxygen species are principally capable of oxidizmg
luminol (23). Nevertheless, the magnitude of response
is minimal and the time course very fast compared
with zymosan-activated neutrophils (3,4). This obser-
vation has led to the general comment that these
oxidizing agents are not by themselves sufficient for
light emission (4).
3. When neutrophils were subjected to the inhibitory
effects of alanine (scavenger of hypochlorous acid),
mannitol (scavenger of hydroxyl radical)* histidine
0 (scavenger of singlet oxygen), *cyanide (inhibitor of
J. Clin. Chem, Clin. Biochem. / Vol. 25^ 1987:/ Nö. 11
Lindena, Burkhardt and Dwenger: Mechanisms of chemiluminescence 775
Superoxide dismutase, myeloperoxidase, catalase)
only slight or moderate Inhibition was observed. So-
dium benzoate (scavenger of hydroxyl radical) and
azide (inhibitor of catalase and Superoxide dismutase)
are more powerful (tab. 5). In luminol-dependent
chemiluminescence Systems the effect of scavengers
and inhibitors of reactive oxygen species is hard to
evaluate. Scavenging, quenching and inhibitory
effects overlap and contradictory results have been
obtained. The relative importance of these oxygen
species äs the source of chemiluminescence has been
reported very differently (3,4, 23).
However, in addition to the importance of the myelo-
peroxidase-H2O2-halide hypothesis (3, 22), which is
supported by our results from myeloperoxidase addi-
tion (tab. 4), it is evident from our inhibitor studies
of arachidonic acid metabolism that this pathway
plays a central role in the chemiluminescence phe-
nomenon.
In the present study we find that established inhibi-
tors of the cyclooxygenase (indometacin) and lipoxy-
genase pathway (nordihydroguaiaretic acid) almost
totally inhibit zymosan-induced chemiluminescence
in whole blood and isolated neutrophils. Both sub-
stances have been reported to inhibit chemilumines-
cence in a dose-dependent manner, the latter being
stronger (4, 25, 26). From these experiments alone,
however, it cannot be deduced whether light emis-
sions is directly or indirectly attributed to the cyclo-
oxygenase or lipoxygeiiase pathway.
However, arachidonic acid metabolism alone via the
cyclooxygenase and/or lipoxygenase pathway is prob-
ably not the source of zymosan-induced chemilumi-
nescence. This is supported by the observation that
neutrophils from patients with chronic granuloma-
tous disease do not respond with zymosan-induced
luminol-enhanced chenüliroinescence, although the
cells are able to metabolize arachidonic acid but lack
the membrane NADPH oxidase and do not produce
oxygen species (24, 26). Nevertheless, there are sev-
eral lines of evideüce which Support the notion that
arachidonic acid metabolism has a pivotäl fole to
play in chemiluminescence generation. Quinacrine,
an inhibitor of arachidonic acid production from
membrane phospholipids presumably by phospho-
lipase A2 Inhibition (4), totally suppresses zymosan*
induced chemiluminescence. Other inhibitors of ara-
chidonic acid metabolism are reagents which, by a
different mode of action, lead to elevated leyels of
cAMP, lifce theophylline and/or dibutyryl cAMP,
prostaglandins and NaF (4, 15). The agents mainly
affect neutrophil response by inhibiting the phos-
phoinositide cycle (4, 15). It has been reported that
agonist-induced phosphoinositide Splitting äs well äs
resynthesis are reduced by procedures aimed at in-
creasing intracellular cAMP (15). A third mode of
action on the neutrophil response is obtained with a
treatment aimed at modulating the calcium concen-
tration by inhibiting the calcium-binding protein cal-
modulin with chlorpromazine. The action of chlor-
promazine has been reported äs Inhibition of the
activity of the calcium-dependent protein kinase C,
phospholipase A2 and the NADPH oxidase (16).
A possible sequence of events leading to the genera-
tion of chemiluminescence by the interaction between
the NADPH oxidase System and arachidonic acid
metabolism is schematically presented in fig. 5. It is
based on the results of the present study and addition-
ally inspired and supported by the reports of Cheung
et al. (4), Bianca et al. (15), Phillips et al. (27), Müller
et al. (28) and Waite (29). The zymosan-induced mem-
brane pertubation leads to the activation of phos-
pholipase C and phospholipase A2 by a binding pro-
tein which, until now, has remained unidentified. A
large propörtion of arachidonic acid released is
derived from phosphatidylinositol, mediated by a
calcium-dependent phospholipase C mechanism, and
from phosphatidylcholine, suggesting a calcium-de-
pendent phospholipase A2 mechanism that could also
explain the release from phosphatidylinositol. In or-
der for arachidonate to be derived from the phospho-
lipase C pathway a lipase must act on the diacylgly-
cerol. The products of phospholipase C action, diacyl-
glycerol and inositol trisphosphate have important
actions without directly entering the arachidonate
cascade. The latter is responsible for the mobilization
of calcium from intracellular Stores and the opening
of plasma membrane calcium channels. Diacylgly-
cerol activates protein kinase C. The activation is
associated with a translocation of cytosol protein
kinase C in the plasma membrane which, in turn,
activates NADPH oxidase by phosphorylation of
some component of the oxidase. Decrease of diacyl-
glycerol, brought about by cAMP, suppresses
NADPH oxidase activation i. e. it suppresses chemi-
luminescence under our experimental conditions. The
oxygen free radicals and their intermediates act
mainly äs oxidants inside and outside the cell but are
not sufficient for light emission. Arachidonic acid is
oxidized via the cyclooxygenase and lipoxygenase
pathway to prostaglandins, thromboxanes and hy-
droperoxyeicosatetraenoic acids and leukotrienes, re-
spectively. These pathways are also insufficient for
light emission. Although the mechanism of interac-
tion between the NADPH oxidase System and arachi-
donic acid metabolism is not yet understood, it clearly
multiplies the response enormously.
J. Clin. Chem. CBn. Biochem. /Vol. 25,1987 / No. 11
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Fig. 5. Diagrammatic Illustration of processes responsible for the generation of zymosan-induced and lumiool-enhanced chemilu-
minescence. Scavengers and metabolic Inhibitors are specified with their mode of action. For further details see text.
Opsonins, receptors
Two main observations are relevant here:
1. Human blood phagocytes respond with chemilu-
minescence on interaction with zymosan and lumi-
nol in the absence of opsonins, and
2. the chemiluminescence is more evident if zymosan
particles become coated with fragments of the
third component of cpmplement. These two as-
pects will be discussed separately.
1. Interaction without opsonins
Contradictory results have been reported concerning
the need for opsonins äs Stimulation parameters of
phagocytes'(7). Our results on chemiluminescence,
however, clearly reveal (tab. 3) that neutrophils, eosi-
nophils and monocytes can all interact with zymosan
in the absence of opsonins. This chemiluminescence
response (CL 2) is 0.6 tp 0.8 of that obserVed in tue
presence of plasma-derived opsonins (CL 1). Schöpf
at al. (20) found similar proportions for neutrophils
and monocytes in response to unspecific äs well äs
opsonin-mediated chemiluminescence. Very recently,
Williams et al. (30) have shown that the major poly-
saccharide component of zymosan responsible for
the chemiluminescence response of granulocytes is
glucan.
2. Interaction in the presence of opsoriins
Human blood phagocytes possess on their surface
distinct phagoeytic receptors for the Fc portion of
immunoglobulin G äs well äs recepjors for surface-
bound cleavage products of the third component of
complement. These include the cömplement receptor
type l (CR 1) and type 3 (CR 3)j recögnizing particle-
0 bound C3b and iC3b, respectively, which are gemeräted
J. Cliri. Chem, Clin. Biochem. / Vol. 25,1987 / No. 11
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by zymosan particles via the alternative pathway
(5—7). We will discuss the rolc of opsonins and thc
role of cell surface receptors separately.
Opsonins
Results from depletion and omission of plasma, and
physical trcatment which affects the third comple-
ment fraction and/or immunoglobulin G permit the
conclusion that C3-derivcd fragments on zymosan are
the major opsonic component; immunoglobulin G is
of minor importance. The complement-independent
chemiluminesccnce rcsponse is triggcred by the opso-
nin-independent glucan polysaccharide component of
zymosan.
The results of chemical treatment with specific anti-
bodics dirccted against C3, C3b and immunoglobulin
G, respectively have to be diflerentiated (tab. 6).
The results with anti-immunoglobulin are critical for
several reasons. Firstly, even highly purified immuno-
globulin G with a negligible number of polymers
induces a dose-dependent Stimulation of neutrophils
s measured by chemiluminescence (31). Secondly,
soluble immunocomplexes are potent activators of
the chemiluminescence response (32). We also ob-
served that the chemiluminescence with immuno-
globulin G alone, without zymosan, is 0.3 of that
measured for the immunoglobulin G-opsonized
zymosan-induced response (absolute values from
tab. 6, not shown). Naturally occurring immuno-
globulin G from plasma, however, in the samc con-
centration r nge, obviously does not respond in this
way (tab. l, tab. 3). This qualifies the values on anti-
immunoglobulin G from tab. 6. The Inhibition studies
with complement antibodies (tab. 6) indicate that iC3b
fixed on zymosan promotes the main chemilumines-
cence response. C3b is of minor importance.
Cell surface receptor
It has been suggested that complement reccptor
type 3 binds to both fixed iC3b and non-opsonized
zymosan i.e. the glucan component, and should bc
inhibitcd by eithcr EDTA or N-acetylglucosamine (5,
7). EDTA blocks the chemiluminescence response
in whole blood and from isolated neutrophils more
completely than N-acctylglucosamine (tab. 6). Thc
effect of both inhibitors with immunoglobulin G s
opsonin is essentially not mcdiated by an effccl on
Fc-receptors, because the dccrease is mainly in thc
non-opsonized zymosan-mediated rcaction. The lat-
ter has already been discussed to be dependcnl on
complement receptor type 3 binding. These results
again confirm our conclusion regarding the secon-
dary importance of immunoglobulin G s opsonin
for zymosan-mediated chemiluminescence.
Several monoclonal antibodies including OKM 1
recognize a cell surface moleculc on neutrophils, and
it is suggested that the antigen recognized by these
antibodies is the iC3b receptor CR 3 (5-7), although
blocking of the chemiluminescence response with
OKM 1 was not very pronounced in our experiments
(tab. 6).
With regard to this, there appears to be a contradic-
tion in the finding that in whole blood the peak
time is shortened by treatments affecting complement
factor type 3 (tab. 1), whereas it lengthens in the
assay with isolated cells (tab. 2, tab. 3); a common
feature was thc feduction of peak maximum values.
It has been shown that granulocytes in whole unsep-
arated blood express relatively few receptors for C3b
(CR 1) or iC3b (CR 3) but substantially more on iso-
lated granulocytes. Isolated cells continue to respond
to Stimuli by furthcr increasing membrane expression
Tab. 6. Influence on neutrophil and whole blood chemiluminescence by chemicals which react with surface membrane receptors
on phagocytes or with opsonins. Results are cxpressed s quotients of chemiluminescence peak maximum values (CL l —
K l, CL 2—K 2) in the presence and in the absencc of these chemicals. Final assay concentration for N-acetylglucosaminc,
EDTA and OKM l were 200mmol/l, 3 mmol/1 and 5 mg/1, respectively. Antisera were diluted according to thc titre.
Neutrophils (0.5 χ ΙΟ5) or whole blood (40 μΐ) were incubated with the chemicals according to the Standard pipctting
schemc in the material and methods section. Chemiluminescence was initiated with non-opsonized zymosan. In addition
to the Standard procedure with autologous plasma (20 μΐ), immunoglobulin G (20 μΐ of a 11 g/l solution) serves s specific
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of these receptors to a greater extent than whole
blood granulocytes. These additional receptors are
likely to be translocated from an intracellular pool
to the surface (6), thus lengthening the peak time
value (tab. l vs. tab. 2, tab. 3). It is advisible, there-
fore, to draw only very cautious conchisions aboüt
whole blood or even in vivo conditions ffom observa-
tions made on isolated cells.
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